Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains

Details for Australian Patent Application No. 2001287274 (hide)

Owner Beth Israel Deaconess Medical Center, Inc.

Inventors Kalluri, Raghuram

Agent Davies Collison Cave

Pub. Number AU-B-2001287274

PCT Pub. Number WO01/73025

Priority 60/192871 29.03.00 US

Filing date 28 March 2001

Wipo publication date 8 October 2001

Acceptance publication date 22 February 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/39 (2006.01) Medicinal preparations containing peptides - Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)

A61K 38/53 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/14 (2006.01) Drugs for disorders of the cardiovascular system

A61P 15/16 (2006.01) Drugs for genital or sexual disorders

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/78 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

22 February 2007 Application Accepted

  Published as AU-B-2001287274

21 June 2007 Standard Patent Sealed

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001287275

2001287273